Open help menu
Live Webinar

From Silent Killer to Curable Disease: The New Era of Hepatitis C

Jason D. Kirby, DO, MBA, DFASAM
|

Information

Date & Time

Description

Hepatitis C (HCV) remains a significant yet often underdiagnosed public health issue, particularly among high-risk populations. This course equips clinicians with practical tools to identify at-risk patients, apply evidence-based screening guidelines, and initiate effective, guideline-driven treatment. Participants will review current epidemiology, the clinical and economic impact of untreated HCV, and key diagnostic strategies. The session also addresses real-world barriers to care and provides actionable approaches to integrate HCV screening and management into routine clinical practice.

Educational Goal

Equip clinicians with the knowledge and tools to identify, screen, and initiate management of Hepatitis C, while understanding its public health impact, financial burden, and real-world barriers to care.

Learning Objectives

Participants will be able to:

  • Describe Hepatitis C (HVC) epidemiology (incidence, prevalence, and trends).

  • Explain the clinical and economic burden of untreated HCV.

  • Apply current screening recommendations from the CDC, USPSTF, and AAFP.

  • Identify patients at risk and interpret diagnostic testing.

  • Implement a guideline-based treatment approach.

  • Recognize system-level barriers to care and propose solutions.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Jason D. Kirby, DO, MBA, DFASAM
Dr. Jason D. Kirby, DO, MBA, DFASAM, is a nationally recognized leader in Addiction Medicine and currently serves as Chief Medical Officer of Recovery Centers of America. Recently named a Distinguished Fellow of ASAM, he brings a unique blend of clinical expertise, policy insight, and strategic leadership to advancing evidence-based addiction care. Dr. Kirby previously served as President of the Tennessee Society of Addiction Medicine and now holds a national leadership role as Treasurer on ASAM’s Executive Board, where he also chairs the Finance Committee. Board-certified in both Addiction Medicine and Family Medicine, his work spans clinical care, healthcare economics, and policy, with a focus on expanding access, improving quality, and shaping the future of addiction treatment. He also contributes to national guidelines and policy through multiple ASAM committees and currently serves as a Health Policy Fellow with AACOM, reflecting his ongoing commitment to driving meaningful change in healthcare systems and patient outcomes.

Financially Sponsored By

  • Recovery Centers of America